Silvercrest Asset Management Group LLC Axonics, Inc. Transaction History

Silvercrest Asset Management Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $1.29 Million - $1.67 Million	26,150 Added 23.82%	135,910 $8.46 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $5.34 Million - $6.86 Million	109,760 New	109,760 $6.16 Million
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $10.5 Million - $15 Million	-239,513 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $65,963 - $96,748	1,319 Added 0.55%	239,513 $13.4 Million
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $1.27 Million - $1.69 Million	-21,491 Reduced 8.28%	238,194 $15.5 Million
Q2 2021 Aug 16, 2021	BUY	$51.39 - $66.9 $1.66 Million - $2.16 Million	32,250 Added 14.18%	259,685 $16.5 Million
Q1 2021 May 17, 2021	BUY	$49.14 - $59.89 $11.2 Million - $13.6 Million	227,435 New	227,435 $13.6 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.